Health & Medicine
The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.
FDA Approves Pancreatic Cancer Drug That May Extend Patient Survival
The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically p…
HighFinerenone Expands Hope for Non-Diabetic Kidney Disease Patients
Three major studies demonstrate finerenone, a kidney-protective drug, effectively slows chronic kidney disease progression across diverse patient populations b…
HighScientists identify toxic senescent cells in Alzheimer's brains as treatment target
Researchers identified rare senescent cells in Alzheimer's brains that could be targeted for treatment. A Phase 2 clinical trial using a repurposed cancer drug…
HighFDA Approves First CRISPR Gene-Correction Trial for Sickle Cell Disease
UC researchers receive FDA approval to begin first-in-human clinical trial using CRISPR to directly correct the sickle cell mutation in patients' own blood ste…
HighTwo Cancer Drugs Show Promise Reversing Alzheimer's Damage in Mice
US researchers identified two FDA-approved cancer drugs—letrozole and irinotecan—that reversed Alzheimer's brain damage in mouse models by reducing tau protein…
MediumAmivantamab-lazertinib combo outperforms standard care in high-risk EGFR lung cancer
A combination of amivantamab antibody and lazertinib significantly outperforms standard treatment in advanced non-small cell lung cancer patients with EGFR mut…
HighCancer Drug Shows Early Promise Against Alzheimer's in Mouse Study
Researchers found that blocking a mutation in brain immune cells called microglia reversed inflammatory damage in mouse models of Alzheimer's disease using an…
MediumResearchers uncover how bacteria survive antibiotics through tolerance, not just resistance
St. Jude researchers discovered that S. pneumoniae bacteria use RNA regulation changes to enter a tolerance state, surviving antibiotics through a bet-hedging…
HighFirst treatment trial launches for Bundibugyo Ebola strain in DRC
A clinical trial has begun in the Democratic Republic of Congo to test the first potential treatments for Bundibugyo Ebola virus, offering hope to residents fa…
HighFDA-Approved Pancreatic Cancer Drug Offers New Hope Beyond Chemotherapy
FDA has approved a new pill for pancreatic cancer treatment, marking a shift from traditional chemotherapy to targeted therapy. A Brandon patient praises the d…
MediumAt-home flu vaccine now available in 34 states, removing barriers to vaccination
AstraZeneca's FluMist nasal spray vaccine is now available for home self-administration in 34 US states, marking the first FDA-approved at-home flu vaccine opt…
HighDRC Enrolls First Patient in Ebola Treatment Trial Amid Outbreak
WHO announces enrollment of first patient in clinical trial for Bundibugyo Ebola treatments in DRC, where 1,400+ cases and 438 deaths have been confirmed since…
HighAustralian-led trial shows personalised mRNA melanoma vaccine cut recurrence risk by 42 per cent
An Australian-led trial found a tailor-made mRNA vaccine, intismeran, added to standard Keytruda therapy cut melanoma recurrence risk by 42 percent at two year…
MediumCruise hantavirus outbreak reaches 11 cases as French patient requires artificial lung
A French passenger on the MV Hondius is critically ill on artificial lung support as a hantavirus outbreak aboard the cruise ship reaches 11 confirmed and susp…
HighChina Approves Libevitug, First Antibody Treatment for Hepatitis D, a Severe Viral Liver Disease With Few Options
China's NMPA granted conditional approval to Huahui Health's Libevitug, a monoclonal antibody for chronic hepatitis D, the first approved HDV treatment in Chin…
MediumHope amid tragedy: Ebola survivors offer lifeline in DRC outbreak
In the Democratic Republic of Congo's Ebola outbreak that has killed over 170, successful patient recoveries are building community trust in treatment centers…
HighOzempic and GLP-1 drugs: how the weight-loss revolution works and what to know
Ozempic and similar GLP-1 receptor agonists are transforming diabetes and weight loss treatment, with clinical trials showing significant results but raising q…
HighFoods and Cholesterol: Separating Dietary Facts from Anti-Pharma Rhetoric
Article promotes dietary approaches to cholesterol management, claiming foods like olive oil, avocados, and oats can replace statin medications and criticizing…
LowKerala oncologist outlines breast cancer warning signs and self-exam steps
Kerala oncologist outlines breast cancer warning signs, risk factors, and self-examination steps, emphasizing that early detection significantly improves treat…
HighHantavirus Genome Stable as US Cruise Patient Cleared of Infection
European health officials confirm hantavirus from a deadly cruise ship outbreak shows no mutations and matches past South American strains. A US doctor initial…
HighNext-gen KRAS inhibitor elisrasib shows stronger response rates than first-generation drugs in lung cancer
Elisrasib, a next-generation KRAS G12C inhibitor, demonstrated higher response rates and longer-lasting tumor responses than first-generation drugs in patients…
HighH5N1 Detected in New Zealand as Global Health Threats Span Bird Flu to Food Contamination
New Zealand confirms first H5N1 bird flu case while Novo Nordisk launches affordable diabetes treatment in South Africa; U.S. faces cyclosporiasis outbreak lin…
HighEli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
Eli Lilly announced plans to seek FDA approval for tirzepatide as a weight loss treatment after clinical trials showed participants lost up to 15.7% of body we…
HighMix-and-match COVID boosters offer immune system flexibility, expert explains
Federal regulators authorized flexible booster shot strategies allowing Americans to receive different COVID-19 vaccine brands than their original shots, with…
HighBioNTech, OncoC4 Report 54% Death Risk Reduction for Lung Cancer Drug Gotistobart
BioNTech and OncoC4's gotistobart demonstrated a 54% reduction in death risk versus chemotherapy in squamous non-small cell lung cancer patients, with median s…
HighCongo's Rare Ebola Strain Spreads Undetected as Scientists Race to Develop Vaccine
WHO upgraded Congo's Ebola outbreak to 'very high' risk as the rare Bundibugyo strain spreads undetected with no approved vaccine or treatment available, affec…
HighEli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
Eli Lilly's oral GLP-1 drug orforglipron helped people with Type 2 diabetes lose 23 pounds in trials, offering a needle-free alternative to injectable medicati…
HighRace Against Time: Three Vaccine Candidates Target Rare Ebola Strain in East Africa
East Africa's Bundibugyo Ebola outbreak lacks approved vaccines or treatments, prompting urgent development of three vaccine candidates and experimental drugs…
HighFDA Approves Wearable Cancer Drug as Global Health Faces Flu, Swine Fever Outbreaks
FDA approves wearable cancer drug delivery while Novo Nordisk launches weekly insulin in India, but bird flu and swine fever outbreaks pose concurrent health t…
MediumMSF Worker Evacuated With Ebola as Congo Outbreak Spirals Beyond Control
A Doctors Without Borders worker contracted Ebola in Congo's largest outbreak and is being evacuated to the Netherlands for treatment, highlighting risks faced…
HighClimate, ecology and urbanization create perfect storm for zoonotic disease spread
Rising temperatures, ecological disruption, and rapid urbanization are creating conditions for animal-borne viruses like hantavirus to spread to humans more fr…
HighHadassah performs world's first alpha radiation treatment for recurrent brain cancer
Jerusalem's Hadassah Medical Center successfully performed the first-ever clinical treatment using Alpha DaRT technology for recurrent glioblastoma, injecting…
HighBlood test could predict Covid-19 mortality risk, study finds
Researchers identified a red cell distribution width (RDW) blood test that correlates with COVID-19 mortality risk, potentially enabling early identification o…
HighDalhousie researchers identify new Ebola variant, propose repurposed drug treatment
Dalhousie University researchers helped identify a novel Bundibugyo ebolavirus variant in Uganda and DRC outbreaks, and identified a potential treatment using…
HighmRNA vaccines safe, effective; cancer treatment potential next frontier
A Lancet review confirms mRNA vaccines are safe and effective against COVID-19, with 87% effectiveness against infection and 94% against mortality. The technol…
HighFrench hantavirus patient on artificial lung as cruise outbreak reaches 11 cases
A French woman infected in a deadly hantavirus outbreak aboard a cruise ship is critically ill on life support, as confirmed cases reach 11. The outbreak, beli…
HighClopidogrel Outperforms Aspirin as Health Sector Faces Policy Shifts
Recent clinical trials show clopidogrel outperforms aspirin for heart disease prevention, while major pharmaceutical deals and CDC vaccine panel changes reshap…
MediumAmerican Doctor Faces Ebola Crisis at Congo Hospital
A U.S. physician working in the Democratic Republic of Congo faces an Ebola outbreak at his hospital, as the WHO warns the epidemic could persist for months wi…
HighFDA approves Wegovy for heart disease prevention, expanding blockbuster weight-loss drug
The FDA approved Wegovy for reducing cardiovascular disease risk in overweight adults, expanding its use beyond obesity treatment. A 5-year study of 17,600 pat…
HighFrench hantavirus patient in critical condition on artificial lung as cruise outbreak spreads
A French woman infected in a cruise ship hantavirus outbreak is critically ill on life support with severe lung and heart complications. The outbreak has reach…
HighAI-aided diagnosis reveals vitamin B6 link in Parkinson's drug side effects
An NHS anaesthetist used AI to identify a vitamin B6 deficiency caused by Parkinson's medication, potentially saving his mother's life from severe seizures. Th…
HighDr. Reddy's Wins Semaglutide Approval as Novo Nordisk Patent Challenge Opens Market
Dr. Reddy's Laboratories secured regulatory approval to manufacture Semaglutide, the active ingredient in weight loss drugs Ozempic and Wegovy, following Novo…
HighNHS prescription drug costs hit £17.2bn record, driven by cancer and respiratory medicines
NHS spending on prescription medicines reached £17.2 billion in 2021-2022, with hospital medicines surging 35% since 2018. Researchers argue many new drugs are…
HighUganda declares victory over Ebola as last patient discharged
Uganda has discharged its last Ebola patient, achieving zero active cases after 20 confirmed infections. Meanwhile, the WHO warns the outbreak in DR Congo is s…
HighFDA Approves Gilead's Hepcludex, First Approved Treatment for Chronic Hepatitis Delta Virus Infection
The FDA approved Gilead's Hepcludex (bulevirtide), the first FDA-approved treatment for chronic hepatitis delta virus infection, for adults with or without com…
MediumFrench hantavirus patient critically ill on artificial lung as cruise outbreak reaches 11 cases
A French woman infected in a deadly hantavirus outbreak aboard a cruise ship is critically ill and on life support. The outbreak has reached 11 reported cases…
HighModerna's XBB-targeted vaccine shows cost, clinical edge over Pfizer rival in German modeling study
A preprint study models Moderna's mRNA-1273.815 vaccine as more cost-effective and clinically beneficial than no vaccination and Pfizer's XBB.1.5 vaccine in Ge…
MediumPatient's persistence leads to rare kidney disease diagnosis and breakthrough treatment
Michelle Williams fought for years to get diagnosed with IC-MPGN, a rare kidney disease affecting 1-4 people per million. A new FDA-approved medication called…
HighContext matters: Why vaccinated people dominate COVID hospital numbers
Expert analysis shows vaccinated people appear overrepresented in hospitals due to high vaccination rates, but unvaccinated individuals face 15x higher ICU ris…
HighAlzheimer's Drug Approvals Split Regulators on Benefits vs. Safety Trade-offs
Global regulators diverge on approving new amyloid-targeting Alzheimer's drugs, with the FDA and UK approving treatments like donanemab while European regulato…
High